KERX Related Analyst Ratings

Mar 12, 2013 02:39 PM Brean Reiterates Buy on Keryx Biopharmaceuticals (KERX)

Feb 4, 2013 02:33 PM Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'

Jan 29, 2013 08:42 AM Oppenheimer Lifs PT on Keryx Biopharmaceuticals (KERX) to $11

Jan 29, 2013 08:37 AM Stifel Nicolaus Boosts Keryx Biopharmaceuticals (KERX) PT to $13

Jan 29, 2013 08:04 AM Burrill Lifts PT on Keryx Biopharmaceuticals (KERX) to $11

Jan 28, 2013 12:48 PM Keryx Biopharmaceuticals (KERX) Gets Another 'Going to $15' Call

Jan 28, 2013 11:27 AM Roth Capital Doubles PT on Keryx (KERX); Sees Another 200% Upside

Dec 13, 2012 08:48 AM Maxim Group Starts Keryx Biopharmaceuticals (KERX) at Buy

Nov 27, 2012 09:15 AM Dawson James Starts Keryx Biopharmaceuticals (KERX) at Market Outperform

Sep 5, 2012 09:31 AM Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Generic Renagel/Renvela Gains Clarity

Jun 22, 2012 10:46 AM Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Opportunities for Zerenex

Jun 11, 2012 08:54 AM Oppenheimer Positive on Keryx Biopharm. (KERX), Says Market Undervaluing Zerenex

May 10, 2012 08:44 AM Roth Capital Upgrades Keryx Biopharmaceuticals (KERX) to Buy

May 10, 2012 08:38 AM Ladenburg Thalmann Upgrades Keryx Biopharmaceuticals (KERX) to Buy

Apr 5, 2012 09:04 AM Oppenheimer Defends Keryx Biopharmaceuticals (KERX), Says Sell-Off Overdone

Apr 3, 2012 10:37 AM Langenberg & Co. Trims Keryx Biopharmaceuticals (KERX) to Hold

Apr 2, 2012 11:09 AM Brean Murray Maintains 'Buy' on Keryx (KERX); Focus Shifts to Less Risky Zerenex

Apr 2, 2012 10:39 AM Roth Capital Downgrades Keryx Biopharmaceuticals (KERX) to Neutral

May 17, 2011 09:22 AM Oppenheimer Starts KERX, CLDX, PSTI, IMMU at Outperform, ONCY at Perform

May 6, 2011 10:28 AM McNicoll Lewis & Vlak Starts Keryx Biopharmaceuticals (KERX) at Buy; Two Strong PhIII Candidates Offer a Compelling Risk/Reward Opportunity

Mar 16, 2011 07:44 AM JMP Starts Keryx (KERX), AEterna Zentaris (AEZS) at Outperform

Sep 1, 2010 09:37 AM Stifel Nicolaus Initiates Coverage on Keryx Biopharmaceuticals (KERX) with a Buy

Apr 5, 2010 03:18 PM Canaccord Adams Maintains a 'Speculative Buy'on AEterna Zentaris (AEZS); Positive FDA Data From Partner Keryx Pharmaceuticals (KERX)

Mar 1, 2010 03:54 PM Rodman & Renshaw Starts Keryx (KERX) at Market Outperform, $6 Price Target

Feb 25, 2010 08:04 AM Roth Capital Initiates Coverage Biotechnology and Drugs KERX & CLDX

Sep 23, 2009 12:57 PM Brean Murray Ups Keryx (KERX) Target to $5 Following Zerenex OLE Trial Results

Mar 11, 2008 09:55 AM Punk Ziegel Downgrades Keryx Biopharmaceuticals (KERX) to Accumulate

Mar 11, 2008 07:28 AM BofA Downgrades Keryx Biopharmaceuticals (KERX) to Neutral

Mar 10, 2008 09:09 AM Jefferies Lowers Keryx Biopharma (KERX) To Hold

Mar 10, 2008 06:59 AM J.P. Morgan Downgrades Keryx Biopharmaceuticals (KERX) to Neutral

Sep 5, 2007 07:55 AM ThinkEquity Starts Keryx Biopharmaceuticals (KERX) at Buy

Nov 2, 2006 10:47 AM Banc of America Starts Keryx Biopharmaceuticals (KERX) at Buy

May 24, 2006 08:39 AM JP Morgan removes Keryx Biopharma (Nasdaq: KERX) from its Focus List

Dec 15, 2005 07:26 AM Banc Of America Starts KERX at Buy

Oct 5, 2005 08:22 AM Rodman and Renshaw Downgraded KERX

Oct 3, 2005 08:25 AM Merrill Lynch Starts KERX at Buy

May 25, 2005 07:26 AM JP Morgan Starts KERX at Overweight; Adds to Focus List

Apr 14, 2005 07:23 AM Bear Stearns Starts KERX at Outperform